Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000
Rhea-AI Summary
Cosmos Health (NASDAQ:COSM) announced on March 11, 2026 the purchase of $600,000 of Bitcoin, raising its total digital asset holdings to $3.1 million across Bitcoin and Ethereum. The company described the buys as part of a disciplined treasury strategy to diversify the balance sheet and maintain financial flexibility.
Management said these digital assets may be monetized if needed to address a discount to book value and to support shareholder-value initiatives.
Positive
- Purchased $600,000 of Bitcoin on March 11, 2026
- Total digital assets increased to $3.1 million
Negative
- Company may monetize digital assets to address discount to book value
- Holdings include volatile crypto assets, exposing treasury to market swings
News Market Reaction – COSM
In the Mar 11 session, COSM gained 1.05%, reflecting a mild positive market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Crypto Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 19 | Real estate valuation | Positive | -5.9% | Company highlighted $15M Athens real estate value exceeding $13.5M market cap. |
| Feb 18 | Retail expansion | Positive | +9.5% | C-Scrub added to Superdrug, expanding UK retail and pharmacy distribution footprint. |
| Feb 18 | Retail expansion | Positive | +9.5% | C-Scrub listing at Tesco, the UK’s largest retailer, broadening nationwide visibility. |
| Feb 17 | Brand showcase | Positive | -4.8% | Showcased nutraceutical and wellness brands at World Health Expo Dubai 2026. |
| Feb 11 | Crypto treasury build | Positive | -2.2% | Purchased $500,000 of Bitcoin, lifting total crypto investments to $2.5M. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Crypto-tagged and balance-sheet-focused announcements have produced mixed reactions, with 3 divergence events and 2 aligned moves. Highly positive retail expansion headlines aligned with strong gains, while asset-valuation and digital-asset updates often saw negative price reactions.
Over recent weeks, Cosmos Health has used the crypto tag for a broad set of balance-sheet and growth updates. These span highlighting $15 million of real estate value exceeding a $13.5 million market cap, expanding C-Scrub distribution through Tesco and Superdrug with reactions of +9.53%, showcasing brands at World Health Expo Dubai, and a $500,000 Bitcoin purchase bringing crypto investments to $2.5 million. Today’s additional Bitcoin buy continues this treasury-focused narrative.
Key Terms
digital assets financial
bitcoin financial
ethereum financial
book value financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the purchase of
Following this purchase, Cosmos Health’s total investment in digital assets has reached
Greg Siokas, CEO of Cosmos Health, stated: "We continue to view select digital assets as an attractive asset class with strong upside potential. Our growing position in Bitcoin and Ethereum reflects a disciplined treasury strategy designed to enhance balance sheet diversification while maintaining financial flexibility. As we continue to expand our core healthcare operations and execute on our broader growth strategy, we believe selectively allocating capital to digital assets can complement our balance sheet and create additional value for shareholders.
At the same time, if the market does not fully recognize the intrinsic value of our Company, these digital assets provide additional financial flexibility and may be monetized to help address the current discount to book value and support initiatives that enhance shareholder value.”
About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com, www.skypremiumlife.com, www.cana.gr, www.zipdoctor.co, www.cloudscreen.gr, as well as LinkedIn and X.
Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website (www.sec.gov). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of any new information, future events, or otherwise.
Investor Relations Contact:
BDG Communications
cosm@bdgcommunications.com
